Primary prevention of ROP: more can be done in all settings

References

• Blencowe H, Lawn JE, Vazquez T, et al. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 2013;74(Suppl 1):35–49. doi: 10.1038/pr.2013.205
   PubMed Web of Science ®Google Scholar
• Hellstrom A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet. 2013;382(9902):1445–1457. doi: 10.1016/S0140-6736(13)60178-6
   PubMed Web of Science ®Google Scholar
• Quinn GE. Retinopathy of prematurity blindness worldwide: phenotypes in the third epidemic. Eye Brain. 2016;8:31–36. doi: 10.2147/EB.S94436
   PubMed Web of Science ®Google Scholar
• Darlow BA, Gilbert CE, Quiroga A. Setting up and improving ROP programs – interaction of neonatology, nursing and ophthalmology. Clin Perinatol. 2013;40(2):215–227. doi: 10.1016/j.clp.2013.02.006
   PubMed Web of Science ®Google Scholar
• Fang JL, Sorita A, Carey WA, et al. Interventions to prevent retinopathy of prematurity: a meta-analysis. Pediatrics. 2016;137(4):e20153387. doi: 10.1542/peds.2015-3387
   PubMed Web of Science ®Google Scholar
• Liegl R, Hellström A, Smith LE. Retinopathy of prematurity: the need for prevention. Eye Brain. 2016;8:91–102. doi: 10.2147/EB.S99038
   PubMed Web of Science ®Google Scholar
• Gilbert C, Blencowe H. Retinopathy of prematurity: it is time to take action. Community Eye Health. 2017;30(99):45–48.
   PubMedGoogle Scholar
• Kim SJ, Port AD, Swan R, et al. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018;63(5):618–637. doi: 10.1016/j.survophthal.2018.04.002
   PubMed Web of Science ®Google Scholar
• Zhang HB, Wang XD, Xu K, et al. The progress of prophylactic treatment in retinopathy of prematurity. Int J Ophthalmol. 2018;11(5):858–873. doi: 10.18240/ijo.2018.05.24
   PubMed Web of Science ®Google Scholar
• Aranda JV, Qu J, Valencia GB, et al. Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity. Semin Perinatol. 2019;43(6):360–366. doi: 10.1053/j.semperi.2019.05.009
   PubMed Web of Science ®Google Scholar
• Darlow BA, Husain S. Primary prevention of ROP and the oxygen saturation targeting trials. Semin Perinatol. 2019;43(6):333–340. doi: 10.1053/j.semperi.2019.05.004
   PubMed Web of Science ®Google Scholar
• Carroll L, Owen LA. Current evidence and outcomes for retinopathy of prematurity prevention: insight into novel maternal and placental contributions. Explor Med. 2020;1(1):4–26. doi: 10.37349/emed.2020.00002
   PubMedGoogle Scholar
• Ryu J. New aspects on the treatment of retinopathy of prematurity: currently available therapies and emerging novel therapeutics. Int J Mol Sci. 2022;23(15):8529. doi: 10.3390/ijms23158529
   PubMed Web of Science ®Google Scholar
• Sabri K, Ells AL, Lee EY, et al. Retinopathy of prematurity: a global perspective and recent developments. Pediatrics. 2022;150(3):e2021053924. doi: 10.1542/peds.2021-053924
   PubMed Web of Science ®Google Scholar
• Gilbert C, Fielder A, Gordillo L, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005;115(5):e518–25. doi: 10.1542/peds.2004-1180
   PubMed Web of Science ®Google Scholar
• Gilbert C, Malik ANJ, Nahar N, et al. Epidemiology of ROP update - Africa is the new frontier. Semin Perinatol. 2019;43(6):317–322. doi: 10.1053/j.semperi.2019.05.002
   PubMed Web of Science ®Google Scholar
• Quinn GE, Barr C, Bremer D, et al. Changes in course of retinopathy of prematurity from 1986 to 2013: comparison of three studies in the United States. Ophthalmol. 2016;123(7):1595–1600. doi: 10.1016/j.ophtha.2016.03.026
   PubMed Web of Science ®Google Scholar
• Holmström G, Tornqvist K, Al-Hawasi A, et al. Increased frequency of retinopathy of prematurity over the last decade and significant regional differences. Acta Ophthalmol. 2018;96(2):142–148. doi: 10.1111/aos.13549
   PubMed Web of Science ®Google Scholar
• Prakalapakorn SG, Greenberg L, Edwards EM, et al. Trends in retinopathy of prematurity screening and treatment: 2008-2018. Pediatrics. 2021;147(6):e2020039966. doi: 10.1542/peds.2020-039966
   PubMed Web of Science ®Google Scholar
• Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008;84(2):77–82. doi: 10.1016/j.earlhumdev.2007.11.009
   PubMed Web of Science ®Google Scholar
• Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens* *from the Massachusetts eye and ear infirmary. this investigation is made possible through the special fund for research for pathology laboratory. I Preliminary Report Am J Ophthalmol. 1942;25(2):203–204. doi: 10.1016/S0002-9394(42)92088-9
   Google Scholar
• Silverman WA. The lesson of retrolental fibroplasia. Sci Am. 1977;236(6):100–107. doi: 10.1038/scientificamerican0677-100
   PubMed Web of Science ®Google Scholar
• Edwards EM, Horbar JD. Retinopathy of prematurity prevention, screening and treatment programmes: The role of neonatal networks. Semin Perinatol. 2019;43(6):341–343. doi: 10.1053/j.semperi.2019.05.005
   PubMed Web of Science ®Google Scholar
• Darlow BA, Hutchinson JL, Simpson JM, et al. Variation in rates of severe retinopathy of prematurity among neonatal intensive care units in the Australian and New Zealand Neonatal Network. Brit J Ophthalmol. 2005;89(12):1592–1596. doi: 10.1136/bjo.2005.073650
   PubMed Web of Science ®Google Scholar
• Thomas K, Shah PS, Canning R, et al. Retinopathy of prematurity: Risk factors and variability in Canadian neonatal intensive care units. J Neonatal Perinatal Med. 2015;8(3):207–214. doi: 10.3233/NPM-15814128
   PubMedGoogle Scholar
• Darlow BA, Lui K, Kusuda S, et al. International variations and trends in the treatment for retinopathy of prematurity. Brit J Ophthalmol. 2017;101(10):1399–1404. doi: 10.1136/bjophthalmol-2016-310041
   PubMed Web of Science ®Google Scholar
• Rysavy MA, Mehler K, Oberthür A, et al. An immature science: intensive care for infants born at ≤23 weeks of gestation. J Pediatr. 2021;233:16–25.e1. doi: 10.1016/j.jpeds.2021.03.006
   PubMed Web of Science ®Google Scholar
• Nair N, Patel RM. The center-effect on outcomes for infants born at less than 25 weeks. Semin Perinatol. 2022;46(1):151538. doi: 10.1016/j.semperi.2021.151538
   PubMed Web of Science ®Google Scholar
• Wang J, Ying GS, Yu Y, et al. Racial differences in retinopathy of prematurity. Ophthalmic Epidemiol. 2023 Jan;16:1–9.
   Google Scholar
• Husain SM, Sinha AK, Bunce C, et al. Relationships between maternal ethnicity, gestational age, birth weight, weight gain, and severe retinopathy of prematurity. J Pediatr. 2013;163(1):67–72. doi: 10.1016/j.jpeds.2012.12.038
   PubMed Web of Science ®Google Scholar
• Montoya-Williams D, Duncan AF, Burris HH. Racial and ethnic perinatal and infant disparities: a comprehensive, diverse and actionable compendium. Semin Perinatol. 2022;46(8):151655. doi: 10.1016/j.semperi.2022.151655
   PubMed Web of Science ®Google Scholar
• Ndukwe T, Cole E, Scanzera AC, et al. Health equity and disparities in ROP care: a need for systematic evaluation. Front Pediatr. 2022;10:806691. doi: 10.3389/fped.2022.806691
   PubMed Web of Science ®Google Scholar
• Hartnett ME, Morrison MA, Smith S, et al. Genetic variants associated with severe retinopathy of prematurity in extremely low birth weight infants. Invest Ophthalmol Vis Sci. 2014;55(10):6194–6203. doi: 10.1167/iovs.14-14841
   PubMed Web of Science ®Google Scholar
• Hartnett ME, Cotten CM. Genomics in the neonatal nursery: Focus on ROP. Semin Perinatol. 2015;39(8):604–610. doi: 10.1053/j.semperi.2015.09.007
   PubMed Web of Science ®Google Scholar
• Darlow BA, Elder MJ, Horwood LJ, et al. Does observer bias contribute to variations in the rate of retinopathy of prematurity between centres? Clin Exp Ophthalmol. 2008;36(1):43–46. doi: 10.1111/j.1442-9071.2007.01652.x
   PubMed Web of Science ®Google Scholar
• Fleck BW, Williams C, Juszczak E, et al. An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting (BOOST) II trials. Eye. 2018;32(1):74–80. doi: 10.1038/eye.2017.150
   PubMed Web of Science ®Google Scholar
• Hartnett ME, Penn JS. Mechanisms and management of retinopathy of prematurity. N Engl J Med. 2012;367(26):2515–2526. doi: 10.1056/NEJMra1208129
   PubMed Web of Science ®Google Scholar
• Smith LE, Hard AL, Hellström A. The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment. Clin Perinatol. 2013;40(2):201–214. doi: 10.1016/j.clp.2013.02.002
   PubMed Web of Science ®Google Scholar
• Ingvaldsen SH, Morken TS, Austeng D, et al. Visuopathy of prematurity: is retinopathy just the tip of the iceberg? Pediatr Res. 2022;91(5):1043–1048. doi: 10.1038/s41390-021-01625-0
   PubMed Web of Science ®Google Scholar
• Lucchesi M, Marracci S, Amato R, et al. Neurosensory alterations in retinopathy of prematurity: a window to neurological impairments associated to preterm birth. Biomedicines. 2022;10(7):1603. doi: 10.3390/biomedicines10071603
   PubMed Web of Science ®Google Scholar
• Gilbert CE, Dawes L, Wise M, et al. Obstetric strategies to reduce blindness from retinopathy of prematurity in infants born preterm. Acta Obstet Gynecol Scand. 2019;98(12):1497–1499. doi: 10.1111/aogs.13684
   PubMed Web of Science ®Google Scholar
• Kindinger LM, David AL. The role of the obstetrician in the prevention of retinopathy of prematurity. Semin Perinatol. 2019;43(6):323–332. doi: 10.1053/j.semperi.2019.05.003
   PubMed Web of Science ®Google Scholar
• McLernon DJ, Harrild K, Bergh C, et al. Clinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trials. BMJ. 2010;341(dec21 2):c6945. doi: 10.1136/bmj.c6945
   PubMedGoogle Scholar
• Kamath MS, Mascarenhas M, Kirubakaran R, et al. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection. Cochrane Database Syst Rev. 2020;8(8): CD003416. doi:10.1002/14651858.CD003416.pub5
   PubMedGoogle Scholar
• Mitra S, Aune D, Speer CP, et al. Chorioamnionitis as a risk factor for retinopathy of prematurity: a systematic review and meta-analysis. Neonatology. 2014;105(3):189–199. doi: 10.1159/000357556
   PubMed Web of Science ®Google Scholar
• Gomez R, Romero R, Ghezzi F, et al. The fetal inflammatory response syndrome. Am J Obstet Gynecol. 1998;179(1):194–202. doi: 10.1016/S0002-9378(98)70272-8
   PubMed Web of Science ®Google Scholar
• Chan-Ling T, Gole GA, Quinn GE, et al. Pathophysiology, screening and treatment of ROP: A multi-disciplinary perspective. Prog Retin Eye Res. 2018;62:77–119. doi: 10.1016/j.preteyeres.2017.09.002
   PubMed Web of Science ®Google Scholar
• Lee J, Dammann O. Perinatal infection, inflammation, and retinopathy of prematurity. Semin Fetal Neonatal Med. 2012;17(1):26–29. doi: 10.1016/j.siny.2011.08.007
   PubMed Web of Science ®Google Scholar
• Dammann O, Rivera JC, Chemtob S. The prenatal phase of retinopathy of prematurity. Acta Paediatrica. 2021;110(9):2521–2528. doi: 10.1111/apa.15945
   PubMed Web of Science ®Google Scholar
• Roberts D, Brown J, Medley N, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3. CD004454.
   PubMed Web of Science ®Google Scholar
• Travers CP, Clark RH, Spitzer AR, et al. Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study. BMJ. 2017;356:j1039. doi: 10.1136/bmj.j1039
   PubMed Web of Science ®Google Scholar
• Yim CL, Tam M, Chan HL, et al. Association of antenatal steroid and risk of retinopathy of prematurity: a systematic review and meta-analysis. Brit J Ophthalmol. 2018;102(10):1336–1341. doi: 10.1136/bjophthalmol-2017-311576
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO recommendations on interventions to improve preterm birth outcomes. Geneva: World Health Organization; 2015. Available from: https://www.who.int/reproductivehealth/publications/maternal_perinatal_health/pretermbirth-guideline/en/
   Google Scholar
• The WHO ACTION Trial Collaborators. Antenatal dexamethasone for early preterm birth in low-resource countries. New Engl J Med. 2020;383(26):2514–2525. doi: 10.1056/NEJMoa2022398
   PubMed Web of Science ®Google Scholar
• Vogel JP, Souza JP, Gülmezoglu AM, et al. for the WHO multi-country survey on maternal and newborn health research network. Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO multicountry survey on maternal and newborn health. Lancet. 2014;384(9957):1869–1877. doi: 10.1016/S0140-6736(14)60580-8
   PubMed Web of Science ®Google Scholar
• Madar J, Roehr CC, Ainsworth S, et al. European resuscitation council guidelines 2021: newborn resuscitation and support of transition of infants at birth. Resuscitation. 2021;161:291–326.
   PubMed Web of Science ®Google Scholar
• Fogarty M, Osborn DA, Askie L, et al. Delayed vs early umbilical cord clamping for preterm infants: a systematic review and meta-analysis. Am J Obstet Gynecol. 2018;218(1):1–18. doi: 10.1016/j.ajog.2017.10.231
   PubMed Web of Science ®Google Scholar
• Seidler AL, Gyte GML, Rabe H, et al. Umbilical cord management for newborns <34 weeks’ gestation: a meta-analysis. Pediatrics. 2021;147(3):e20200576. doi: 10.1542/peds.2020-0576
   PubMed Web of Science ®Google Scholar
• McCall EM, Alderdice F, Halliday HL, et al. Interventions to prevent hypothermia at birth in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2018;2(2): CD004210. doi:10.1002/14651858.CD004210.pub5.
   PubMedGoogle Scholar
• Leadford AE, Warren JB, Manasyan A, et al. Plastic bags for prevention of hypothermia in preterm and low birth weight infants. Pediatrics. 2013;132(1):e128–34. doi: 10.1542/peds.2012-2030
   PubMed Web of Science ®Google Scholar
• Lyu Y, Shah PS, Ye XY, et al. Association between admission temperature and mortality and major morbidity in preterm infants born at fewer than 33 weeks’ gestation. JAMA Pediatr. 2015;169(4):e150277. doi: 10.1001/jamapediatrics.2015.0277
   PubMed Web of Science ®Google Scholar
• Keszler M. Novel ventilation strategies to reduce adverse pulmonary outcomes. Clin Perinatol. 2022;49(1):219–242. doi: 10.1016/j.clp.2021.11.019
   PubMed Web of Science ®Google Scholar
• Oei JL, Finer NN, Saugstad OD, et al. Outcomes of oxygen saturation targeting during delivery room stabilisation of preterm infants. Arch Dis Child Fetal Neonatal Ed. 2018;103(5):F446–F454. doi: 10.1136/archdischild-2016-312366
   PubMed Web of Science ®Google Scholar
• Saugstad OD, Robertson NJ, Vento M. A critical review of the 2020 International liaison committee on resuscitation treatment recommendations for resuscitating the newly born infant. Acta Paediatr. 2021;110(4):1107–1112. doi: 10.1111/apa.15754
   PubMed Web of Science ®Google Scholar
• Shah PK, Narendran V, Kalpana N. Aggressive posterior retinopathy of prematurity in large preterm babies in South India. Arch Dis Child Fetal Neonatal Ed. 2012;97(5):F371–F375. doi: 10.1136/fetalneonatal-2011-301121
   PubMed Web of Science ®Google Scholar
• Hartnett ME. Pathophysiology and mechanisms of severe retinopathy of prematurity. Ophthalmol. 2015;122(1):200–210. doi: 10.1016/j.ophtha.2014.07.050
   PubMed Web of Science ®Google Scholar
• Alberman E, Benson J, McDonald A. Cerebral palsy and severe educational subnormality in low-birthweight children: a comparison of births in 1951-53 and 1970-73. Lancet. 1982;1(8272):606–608. doi: 10.1016/S0140-6736(82)91759-7
   PubMed Web of Science ®Google Scholar
• Cross KW. Cost of preventing retrolental fibroplasia? Lancet. 1973;2(7835):954–956. doi: 10.1016/S0140-6736(73)92610-X
   PubMed Web of Science ®Google Scholar
• Cole CH, Wright KW, Tarnow-Mordi W, et al. Resolving our uncertainty about oxygen therapy. Pediatrics. 2003;112(6 Pt 1):1415–1419. doi: 10.1542/peds.112.6.1415
   PubMed Web of Science ®Google Scholar
• Askie LM, Brocklehurst P, Darlow BA, et al. Neonatal oxygen prospective meta-analysis collaboration study protocol. BMC Pediatr. 2011;11(1):6. doi: 10.1186/1471-2431-11-6
   PubMedGoogle Scholar
• SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research NetworkCarlo WA, Finer NN, et al. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010;362(21):1959–1969. doi:10.1056/NEJMoa0911781
   PubMed Web of Science ®Google Scholar
• Askie L, Darlow BA, Finer N, et al. Association between oxygen saturation targeting and death or disability in extremely preterm infants in the neonatal oxygenation prospective meta-analysis collaboration. JAMA. 2018;319(21):2190–2201. doi: 10.1001/jama.2018.5725
   PubMed Web of Science ®Google Scholar
• Sola A, Golombek SG, Montes Bueno MT, et al. Safe oxygen saturation targeting and monitoring in preterm infants: can we avoid hypoxia and hyperoxia? Acta Paediatr. 2014;103(10):1009–1018. doi: 10.1111/apa.12692
   PubMed Web of Science ®Google Scholar
• Cummings JJ, Polin RA, Watterberg KL. Committee on fetus and newborn. oxygen targeting in extremely low birth weight infants. Pediatrics. 2016;138(2):e20161576. doi: 10.1542/peds.2016-1576
   PubMed Web of Science ®Google Scholar
• Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome - 2019 Update. Neonatology. 2019;115(4):432–450. doi: 10.1159/000499361
   PubMed Web of Science ®Google Scholar
• Walker PJB, Bakare AA, Ayede AI, et al. Using intermittent pulse oximetry to guide neonatal oxygen therapy in a low-resource context. Arch Dis Child Fetal Neonatal Ed. 2020;2020105(3):316–321. doi: 10.1136/archdischild-2019-317630
   Google Scholar
• Gantz MG, Carlo WA, Finer NN, et al. Achieved oxygen saturations and retinopathy of prematurity in extreme preterms. Arch Dis Child Fetal Neonatal Ed. 2020;105(2):138–144. doi: 10.1136/archdischild-2018-316464
   PubMed Web of Science ®Google Scholar
• Lim K, Wheeler KI, Gale TJ, et al. Oxygen saturation targeting in preterm infants receiving continuous positive airway pressure. J Pediatr. 2014;164(4):730–736.e1. doi: 10.1016/j.jpeds.2013.11.072
   PubMed Web of Science ®Google Scholar
• Hagadorn JI, Furey AM, Nghiem TH, et al. Achieved versus intended pulse oximeter saturation in infants born less than 28 weeks’ gestation: the AVIOx study pediatrics. Pediatrics. 2006;118(4):1574–1582. doi: 10.1542/peds.2005-0413
   PubMed Web of Science ®Google Scholar
• Sink DW, Hope SA, Hagadorn JI. Nurse: patient ratio and achievement of oxygen saturation goals in premature infants. Arch Dis Child Fetal Neonatal Ed. 2011;96(2):F93–8. doi: 10.1136/adc.2009.178616
   PubMed Web of Science ®Google Scholar
• Vagedes J, Poets CF, Dietz K. Averaging time, desaturation level, duration and extent. Arch Dis Child Fetal Neonatal Ed. 2013;98(3):F265–6. doi: 10.1136/archdischild-2012-302543
   PubMed Web of Science ®Google Scholar
• Chow LC, Wright KW, Sola A, et al. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics. 2003;111(2):339–4. doi: 10.1542/peds.111.2.339
   PubMed Web of Science ®Google Scholar
• Darlow BA, Marschner S, Donoghoe M, et al. Randomized controlled trial of oxygen saturation targets in very preterm infants: two year outcomes. J Pediatr. 2014;165(1):30–35. doi: 10.1016/j.jpeds.2014.01.017
   PubMed Web of Science ®Google Scholar
• Srivatsa B, Malcolm K, Clark RH, et al. Effect of a novel oxygen saturation targeting strategy on mortality, retinopathy of prematurity, and bronchopulmonary dysplasia in neonates born extremely preterm. J Pediatr. 2021;234:33–37.e3. doi: 10.1016/j.jpeds.2021.03.007
   PubMed Web of Science ®Google Scholar
• Poets CF, Franz AR. Automated FiO2 control: nice to have, or an essential addition to neonatal intensive care? Arch Dis Child Fetal Neonatal Ed. 2017;102(1):F5–F6. doi: 10.1136/archdischild-2016-311647
   PubMed Web of Science ®Google Scholar
• Maiwald CA, Niemarkt HJ, Poets CF, et al. Effects of closed-loop automatic control of the inspiratory fraction of oxygen (FiO2-C) on outcome of extremely preterm infants - study protocol of a randomized controlled parallel group multicenter trial for safety and efficacy. BMC Pediatr. 2019;19(1):363. doi: 10.1186/s12887-019-1735-9
   PubMed Web of Science ®Google Scholar
• Di Fiore JM, Bloom JN, Orge F, et al. A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity. J Pediatr. 2010;157(1):69–73. doi: 10.1016/j.jpeds.2010.01.046
   PubMed Web of Science ®Google Scholar
• Poets CF, Roberts RS, Schmidt B, et al. Association between intermittent hypoxemia or bradycardia and late death or disability in extremely preterm infants. JAMA. 2015 Aug 11;314(6):595–603. doi: 10.1001/jama.2015.8841
   PubMed Web of Science ®Google Scholar
• Shukla A, Sonnie C, Worley S, et al. Comparison of biphasic vs static oxygen saturation targets among infants with retinopathy of prematurity. JAMA Ophthalmol. 2019;137(4):417–423. doi: 10.1001/jamaophthalmol.2018.7021
   PubMed Web of Science ®Google Scholar
• STOP-ROP Investigators. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics. 2000;105(2):295–310. doi: 10.1542/peds.105.2.295
   PubMed Web of Science ®Google Scholar
• Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357(19):1893–1902. doi: 10.1056/NEJMoa073679
   PubMed Web of Science ®Google Scholar
• Mürner-Lavanchy IM, Doyle LW, Schmidt B, et al. Neurobehavioral outcomes 11 years after neonatal caffeine therapy for apnea of prematurity. Pediatrics. 2018;141(5):e20174047. doi: 10.1542/peds.2017-4047
   PubMed Web of Science ®Google Scholar
• Ekhaguere OA, Ayede AI, Ezeaka CV. Is caffeine available and affordable in low and middle-income countries? A survey in sub-Saharan Africa. Semin Fetal Neonatal Med. 2020;25(6):101182. doi: 10.1016/j.siny.2020.101182
   PubMed Web of Science ®Google Scholar
• Harding JE, Cormack BE, Alexander T, et al. Advances in nutrition of the newborn infant. Lancet. 2017;389(10079):1660–1668. doi: 10.1016/S0140-6736(17)30552-4
   PubMed Web of Science ®Google Scholar
• Bharwani SK, Green BF, Pezzullo JC, et al. Systematic review and meta-analysis of human milk intake and retinopathy of prematurity: a significant update. J Perinatol. 2016;36(11):913–920. doi: 10.1038/jp.2016.98
   PubMed Web of Science ®Google Scholar
• Miller J, Tonkin E, Damarell RA, et al. A systematic review and meta-analysis of human milk feeding and morbidity in very low birth weight infants. Nutrients. 2018;10(6):707. doi: 10.3390/nu10060707
   PubMed Web of Science ®Google Scholar
• Löfqvist C, Engström E, Sigurdsson J, et al. Postnatal head growth deficit among premature infants parallels retinopathy of prematurity and insulin-like growth factor-1 deficit. Pediatrics. 2006;117(6):1930–1938. doi: 10.1542/peds.2005-1926
   PubMed Web of Science ®Google Scholar
• Hellström A, Hård AL, Engström E, et al. Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening. Pediatrics. 2009;123(4):e638–45. doi: 10.1542/peds.2008-2697
   PubMed Web of Science ®Google Scholar
• Lin L, Binenbaum G. Postnatal weight gain and retinopathy of prematurity. Semin Perinatol. 2019;43(6):352–359. doi: 10.1053/j.semperi.2019.05.008
   PubMed Web of Science ®Google Scholar
• Löfqvist C, Hansen-Pupp I, Andersson E, et al. Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I. Arch Ophthalmol. 2009;127(5):622–627. doi: 10.1001/archophthalmol.2009.69
   PubMedGoogle Scholar
• Binenbaum G, Tomlinson LA, de Alba Campomanes AG, et al. Validation of the postnatal growth and retinopathy of prematurity screening criteria. JAMA Ophthalmol. 2020;138(1):31–37. doi: 10.1001/jamaophthalmol.2019.4517
   PubMed Web of Science ®Google Scholar
• Klevebro S, Westin V, Stoltz Sjöström E, et al. Early energy and protein intakes and associations with growth, BPD, and ROP in extremely preterm infants. Clin Nutr. 2019;38(3):1289–1295. doi: 10.1016/j.clnu.2018.05.012
   PubMed Web of Science ®Google Scholar
• Bloomfield FH, Jiang Y, Harding JE, et al. Early amino acids in extremely preterm infants and neurodisability at 2 years. N Engl J Med. 2022;387(18):1661–1672. doi: 10.1056/NEJMoa2204886
   PubMed Web of Science ®Google Scholar
• Gill A. The Australian and New Zealand neonatal network. analysis of neonatal nosocomial infection rates across the Australian and New Zealand Neonatal Network. J Hosp Infect. 2009;72(2):155–162. doi: 10.1016/j.jhin.2009.02.018
   PubMed Web of Science ®Google Scholar
• Chiang MF, Arons RR, Flynn JT, et al. Incidence of retinopathy of prematurity from 1996 to 2000: analysis of a comprehensive New York state patient database. Ophthalmol. 2004;111(7):1317–1325. doi: 10.1016/j.ophtha.2003.10.030
   PubMed Web of Science ®Google Scholar
• Klinger G, Levy I, Sirota L, et al. Outcome of early-onset sepsis in a national cohort of very low birth weight infants. Pediatrics. 2010;125(4):e736–40. doi: 10.1542/peds.2009-2017
   PubMed Web of Science ®Google Scholar
• Tolsma KW, Allred EN, Chen ML, et al. Neonatal bacteremia and retinopathy of prematurity: the ELGAN study. Arch Ophthalmol. 2011;129(12):1555–1563. doi: 10.1001/archophthalmol.2011.319
   PubMedGoogle Scholar
• Huang J, Tang Y, Zhu T, et al. Cumulative evidence for association of sepsis and retinopathy of prematurity. Medicine (Baltimore). 2019;98(42):e17512. doi: 10.1097/MD.0000000000017512
   PubMed Web of Science ®Google Scholar
• Wang X, Tang K, Chen L, et al. Association between sepsis and retinopathy of prematurity: a systematic review and meta-analysis. BMJ Open. 2019;9(5):e025440. doi: 10.1136/bmjopen-2018-025440
   PubMed Web of Science ®Google Scholar
• Huncikova Z, Vatne A, Stensvold HJ, et al. Late-onset sepsis in very preterm infants in Norway in 2009–2018: a population-based study. Arch Dis Child Fetal Neonatal Ed. Feb 2: Online ahead of print. 2023;fetalneonatal-2022–324977. doi: 10.1136/archdischild-2022-324977
   Google Scholar
• Bharwani SK, Dhanireddy R. Systemic fungal infection is associated with the development of retinopathy of prematurity in very low birth weight infants: a meta-review. J Perinatol. 2008;28(1):61–66. doi: 10.1038/sj.jp.7211878
   PubMed Web of Science ®Google Scholar
• Noyola DE, Bohra L, Paysse EA, et al. Association of candidemia and retinopathy of prematurity in very low birthweight infants. Ophthalmol. 2002;109(1):80–84. doi: 10.1016/S0161-6420(01)00841-7
   PubMed Web of Science ®Google Scholar
• Karlowicz MG, Giannone PJ, Pestian J, et al. Does candidemia predict threshold retinopathy of prematurity in extremely low birth weight (=1000 g) neonates?. Pediatrics. 2000;105(5):1036–1040. doi: 10.1542/peds.105.5.1036
   PubMed Web of Science ®Google Scholar
• Gill AW, Keil AD, Jones C, et al. Tracking neonatal nosocomial infection: the continuous quality improvement cycle. J Hosp Infect. 2011;78(1):20–25. doi: 10.1016/j.jhin.2010.12.018
   PubMed Web of Science ®Google Scholar
• Fisher D, Cochran KM, Provost LP, et al. Reducing central line-associated bloodstream infections in North Carolina NICUs. Pediatrics. 2013;132(6):e1664–71. doi: 10.1542/peds.2013-2000
   PubMed Web of Science ®Google Scholar
• Mobley RE, Bizzarro MJ. Central line-associated bloodstream infections in the NICU: Successes and controversies in the quest for zero. Semin Perinatol. 2017;41(3):166–174. doi: 10.1053/j.semperi.2017.03.006
   PubMed Web of Science ®Google Scholar
• Suresh GK, Edwards WH. Central line-associated bloodstream infections in neonatal intensive care: changing the mental model from inevitability to preventability. Am J Perinatol. 2012;29(1):57–64. doi: 10.1055/s-0031-1286182
   PubMed Web of Science ®Google Scholar
• Fitzgerald FC, Zingg W, Chimhini G, et al. The Impact of interventions to prevent neonatal healthcare-associated infections in low- and middle-income countries: a systematic review. Pediatr Infect Dis J. 2022;41(3S):S26–S35. doi: 10.1097/INF.0000000000003320
   PubMed Web of Science ®Google Scholar
• Ley D, Hallberg B, Hansen-Pupp I, et al. RhIGF-1/RhIGFBP-3 in preterm infants: a phase 2 randomized controlled trial. J Pediatr. 2019;206:56–65.e8. doi: 10.1016/j.jpeds.2018.10.033
   PubMed Web of Science ®Google Scholar
• Hallman M, Bry K, Hoppu K, et al. M. Inositol supplementation in premature infants with respiratory distress syndrome. N Engl J Med. 1992;326(19):1233–1239. doi: 10.1056/NEJM199205073261901
   PubMed Web of Science ®Google Scholar
• Phelps DL, Watterberg KL, Nolen TL, et al. Effects of Myo-inositol on type 1 retinopathy of prematurity among preterm infants <28 weeks’ gestational age: a randomized clinical trial. JAMA. 2018;320(16):1649–1658. doi: 10.1001/jama.2018.14996
   PubMed Web of Science ®Google Scholar
• Manzoni P, Rinaldi M, Cattani S, et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA. 2009;302(13):1421–1428. doi: 10.1001/jama.2009.1403
   PubMed Web of Science ®Google Scholar
• Griffiths J, Jenkins P, Vargova M. ELFIN trial investigators group. Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial. Lancet. 2019;393(10170):423–433. doi: 10.1016/S0140-6736(18)32221-9
   PubMed Web of Science ®Google Scholar
• Tarnow-Mordi WO, Abdel-Latif ME, Martin A, et al. The effect of lactoferrin supplementation on death or major morbidity in very low birthweight infants (LIFT): a multicentre, double-blind, randomised controlled trial. Lancet Child Adolesc Health. 2020;4(6):444–454. doi: 10.1016/S2352-4642(20)30093-6
   PubMedGoogle Scholar
• Reynolds JD, Hardy RJ, Kennedy KA, et al. Lack of efficacy of light reduction in preventing retinopathy of prematurity. N Engl J Med. 1998;338(22):1572–1576. doi: 10.1056/NEJM199805283382202
   PubMed Web of Science ®Google Scholar
• Chan-Ling T, Barnett NL, Maccarone R, et al. Dark-Rearing (DR) precludes the initiating event in OIR and eliminates the pathology seen in the second phase of disease: Rationale for novel non-invasive treatment for ROP. IOVS. 2016;57(12):Abs 4764.
   Web of Science ®Google Scholar
• Kirpalani H, Whyte RK, Andersen C, et al. The premature infants in need of transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006;149(3):301–307. doi: 10.1016/j.jpeds.2006.05.011
   PubMed Web of Science ®Google Scholar
• Kirpalani H, Bell EF, Hintz SR, et al. Higher or lower hemoglobin transfusion thresholds for preterm infants. N Engl J Med. 2020;383(27):2639–2651. doi: 10.1056/NEJMoa2020248
   PubMed Web of Science ®Google Scholar
• Franz AR, Engel C, Bassler D, et al. Effects of liberal vs restrictive transfusion thresholds on survival and neurocognitive outcomes in extremely low-birth-weight infants: the ETTNO randomized clinical trial. JAMA. 2020;324(6):560–570. doi: 10.1001/jama.2020.10690
   PubMed Web of Science ®Google Scholar
• Ohlsson A, Aher SM. Early erythropoiesis-stimulating agents in preterm or low birth weight infants. Cochrane Database Syst Rev. 2020;2(2):CD004863. doi: 10.1002/14651858.CD004863.pub6
   PubMedGoogle Scholar
• Mayock DE, Xie Z, Comstock BA, et al. High-dose erythropoietin in extremely low gestational age neonates does not alter risk of retinopathy of prematurity. Neonatology. 2020;117(5):650–657. doi: 10.1159/000511262
   PubMed Web of Science ®Google Scholar
• Calkins KL, Puder M, Gura K. The evolving use of intravenous lipid emulsions in the neonatal intensive care unit. Semin Perinatol. 2019;43(7):151155. doi: 10.1053/j.semperi.2019.06.003
   PubMed Web of Science ®Google Scholar
• Brion LP, Bell EF, Raghuveer TS. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2003; 4 CD003665 2010(1): 10.1002/14651858.CD003665
   Google Scholar
• Tyson JE, Wright LL, Oh W, et al. Vitamin a supplementation for extremely-low-birth-weight infants. N Engl J Med. 1999;340(25):1962–1968. doi: 10.1056/NEJM199906243402505
   PubMed Web of Science ®Google Scholar
• Darlow BA, Graham PJ, Rojas-Reyes MX. Vitamin a supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants. Cochrane Database Syst Rev. 2016;2016(8): CD000501. doi:10.1002/14651858.CD000501.pub4.
   PubMedGoogle Scholar
• Darlow BA. Vitamin a supplementation for very preterm infants back on the menu-for some or all? Am J Clin Nutr. 2021;114(6):1888–1889. doi: 10.1093/ajcn/nqab328
   PubMed Web of Science ®Google Scholar
• Rakshasbhuvankar AA, Pillow JJ, Simmer KN, et al. Vitamin a supplementation in very-preterm or very-low-birth-weight infants to prevent morbidity and mortality: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr. 2021;114(6):2084–2096. doi: 10.1093/ajcn/nqab294
   PubMed Web of Science ®Google Scholar
• Connor KM, SanGiovanni JP, Lofqvist C, et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med. 2007;13(7):868–873. doi: 10.1038/nm1591
   PubMed Web of Science ®Google Scholar
• Makrides M, Gibson RA, McPhee AJ, et al. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA. 2009;301(2):175–182. doi: 10.1001/jama.2008.945
   PubMed Web of Science ®Google Scholar
• Collins CT, Makrides M, McPhee AJ, et al. Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants. N Engl J Med. 2017;376(13):1245–1255. doi: 10.1056/NEJMoa1611942
   PubMed Web of Science ®Google Scholar
• Hellström A, Nilsson AK, Wackernagel D, et al. Effect of enteral lipid supplement on severe retinopathy of prematurity: a randomized clinical trial. JAMA Pediatr. 2021;175(4):359–367. doi: 10.1001/jamapediatrics.2020.5653
   PubMed Web of Science ®Google Scholar
• Filippi L, Cavallaro G, Bagnoli P, et al. Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives. J Pediatr. 2013;163(6):1570–7.e6. doi: 10.1016/j.jpeds.2013.07.049
   PubMed Web of Science ®Google Scholar
• Kaempfen S, Neumann RP, Jost K, et al. Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants. Cochrane Database Syst Rev. 2018;3(3): CD011893. doi:10.1002/14651858.CD011893.pub2.
   PubMedGoogle Scholar
• Stritzke A, Kabra N, Kaur S, et al. Oral propranolol in prevention of severe retinopathy of prematurity: a systematic review and meta-analysis. J Perinatol. 2019;39(12):1584–1594. doi: 10.1038/s41372-019-0503-x
   PubMed Web of Science ®Google Scholar
• Kong HB, Zheng GY, He BM, et al. Clinical efficacy and safety of propranolol in the prevention and treatment of retinopathy of prematurity: a meta-analysis of randomized controlled trials. Front Pediatr. 2021;9:631673. doi: 10.3389/fped.2021.631673
   PubMed Web of Science ®Google Scholar
• Bührer C, Erdeve Ö, Bassler D, et al. Oral propranolol for prevention of threshold retinopathy of prematurity (ROPROP): protocol of a randomised controlled trial. BMJ Open. 2018;8(7):e021749. doi: 10.1136/bmjopen-2018-021749
   PubMed Web of Science ®Google Scholar
• Filippi L, Cavallaro G, Bagnoli P, et al. Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial. Pediatr Res. 2017;81(2):307–314. doi: 10.1038/pr.2016.230
   PubMed Web of Science ®Google Scholar
• Filippi L, Cavallaro G, Berti E, et al. Propranolol 0.2% eye micro-drops for retinopathy of prematurity: a prospective phase IIB study. Front Pediatr. 2019;7:180. doi: 10.3389/fped.2019.00180
   PubMed Web of Science ®Google Scholar
• Filippi L, Cammalleri M, Amato R, et al. Decoupling oxygen tension from retinal vascularization as a new perspective for management of retinopathy of prematurity. New opportunities from β-adrenoceptors. Front Pharmacol. 2022;13:835771. doi: 10.3389/fphar.2022.835771
   PubMed Web of Science ®Google Scholar
• Sinclair JC. Evidence-based therapy in neonatology: distilling the evidence and applying it in practice. Acta Paediatr. 2004;93(9):1146–1152. doi: 10.1111/j.1651-2227.2004.tb02738.x
   PubMed Web of Science ®Google Scholar
• Zeitlin J, Manktelow BN, Piedvache A, et al. Use of evidence based practices to improve survival without severe morbidity for very preterm infants: results from the EPICE population based cohort. BMJ. 2016;354:i2976.
   PubMedGoogle Scholar
• Payne NR, Finkelstein MJ, Liu M, et al. NICU practices and outcomes associated with 9 years of quality improvement collaboratives. Pediatrics. 2010;125(3):437–446. doi: 10.1542/peds.2009-1272
   PubMed Web of Science ®Google Scholar
• Ellsbury DL, Clark RH, Ursprung R, et al. A multifaceted approach to improving outcomes in the NICU: the pediatrix 100 000 babies campaign. Pediatrics. 2016;137(4):e20150389. doi: 10.1542/peds.2015-0389
   PubMed Web of Science ®Google Scholar
• Lee SK, Beltempo M, McMillan DD, et al. Outcomes and care practices for preterm infants born at less than 33 weeks’ gestation: a quality-improvement study. CMAJ. 2020;192(4):E81–E91. doi: 10.1503/cmaj.190940
   PubMed Web of Science ®Google Scholar
• Pearlman SA. Advancements in neonatology through quality improvement. J Perinatol. 2022;42(10):1277–1282. doi: 10.1038/s41372-022-01383-9
   PubMed Web of Science ®Google Scholar
• Horbar JD, Edwards EM, Greenberg LT, et al. Variation in performance of neonatal intensive care units in the United States. JAMA Pediatr. 2017;171(3):e164396. doi: 10.1001/jamapediatrics.2016.4396
   PubMed Web of Science ®Google Scholar
• Deorari A, Darlow BA. Prevention of sight threatening ROP – neonatologist perspective. Community Eye Health J. 2017;30:52–54.
   Google Scholar
• Vinekar A, Jayadev C, Kumar S, et al. Impact of improved neonatal care on the profile of retinopathy of prematurity in rural neonatal centers in India over a 4-year period. Eye Brain. 2016;8:45–53. doi: 10.2147/EB.S98715
   PubMedGoogle Scholar
• Gordillo L, Villanueva AM, Quinn GE. A practical method for reducing blindness due to retinopathy of prematurity in a developing country. J Perinat Med. 2012;40(5):577–582. doi: 10.1515/jpm-2011-0225
   PubMed Web of Science ®Google Scholar
• Alda E, Lomuto CC, Benítez AM, et al. Results of the national program for the prevention of blindness in childhood by retinopathy of prematurity in Argentina (2004-2016). Arch Argent Pediatr. 2018;116(6):386–393.
   PubMed Web of Science ®Google Scholar
• D’Apremont I, Marshall G, Musalem C, et al. Trends in perinatal practices and neonatal outcomes of very low birth weight infants during a 16-year period at NEOCOSUR centers. J Pediatr. 2020;225:44–50.e1. doi: 10.1016/j.jpeds.2020.05.040
   PubMed Web of Science ®Google Scholar
• Steurer MA, Adams M, Bacchetti P, et al. Swiss medical centres vary significantly when it comes to outcomes of neonates with a very low gestational age. Acta Paediatr. 2015;104(9):872–879. doi: 10.1111/apa.13047
   PubMed Web of Science ®Google Scholar
• Kaempf JW, Wang L, Dunn M. Using a composite morbidity score and cultural survey to explore characteristics of high proficiency neonatal intensive care units. Arch Dis Child Fetal Neonatal Ed. 2019;104(1):F13–F17. doi: 10.1136/archdischild-2017-313715
   PubMed Web of Science ®Google Scholar
• Retinopathy of prematurity: practical approaches to prevent blindness. https://www.lshtm.ac.uk/study/courses/short-courses/free-online-courses/retinopathy-of-prematurity (Accessed 26 Jul 2023)
   Google Scholar
• Facility-based care of the preterm infant: eliminating ROP by improving quality of care. https://www.pretermcare-eliminatingrop.com/ (Accessed 26 Jul 2023)
   Google Scholar